Reaction
Hypertensive Nephropathy reporting signals
As of the last recalculation, Hypertensive Nephropathy appears in 1,065 FAERS reports alongside 18 co-occurring drug terms. The strongest observed disproportionality signal is LANSOPRAZOLE (PRR 197.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Lansoprazole | 671 | 197.3 | 198.1 |
| Esomeprazole | 199 | 76.9 | 77.1 |
| Esomeprazole Magnesium | 429 | 59.3 | 59.4 |
| Omeprazole Magnesium | 530 | 45.1 | 45.2 |
| Dexlansoprazole | 68 | 34.0 | 34.0 |
| Esomeprazole Magnesium Capsule, Delayed Release | 24 | 33.0 | 33.1 |
| Esomeprazole Magnesium Delayed Release Capsules | 24 | 33.0 | 33.1 |
| Esomeprazole Magnesium Dihydrate | 24 | 32.9 | 33.0 |
| Pantoprazole | 277 | 28.6 | 28.6 |
| Omeprazole | 333 | 27.0 | 27.0 |
| Pantoprazole Sodium | 157 | 24.1 | 24.1 |
| Tenofovir Disoproxil Fumarate Tablets | 4 | 9.1 | 9.1 |
| Dolutegravir Sodium | 4 | 8.7 | 8.7 |
| Paricalcitol | 5 | 6.9 | 6.9 |
| Emtricitabine And Tenofovir Alafenamide | 4 | 6.9 | 6.9 |
| Tenofovir Disoproxil Fumarate | 11 | 6.6 | 6.6 |
| Minoxidil Foam 5% (Womens) | 6 | 3.6 | 3.6 |
| Minoxidil | 6 | 2.6 | 2.6 |